The Genome as a Tool for Drug Discovery and Development the Case for Embracing Complexity

21 October 2006 , By Dr Kenneth C. Carter , Fall 2006
Posted in Archive, Enabling Technologies | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The Genome as a Tool for Drug Discovery and Development the Case for Embracing Complexity By Dr Kenneth C. Carter Conventional drug discovery and development is centred on a paradigm in which 'validated' targets are subjected to in vitro screens for the identification of new drug candidates. Molecular profiling using genomic approaches is becoming an [...]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!

Suggested Reading

Stem Cell Differentiation
6 August 2020 , By Dr Lilian Hook

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free